WellCare


At a Glance

  • Revenues up $300M; EBIDTA up $60M
  • Increased market attention in September
  • Overall price decline for quarter
  • Hiring above sector trends in August
  • 2 plans divested to Anthem (MO and NE) as part of Centene Deal

Rolling 12 months financials

Year over year financials


Stock Performance

MA = moving average; GSPC = S&P 500

Analyst buy/sell recommendations

Insider sentiment for quarter- Positive

Based on trading behaviors of company officers and directors trading in their own stock


Earnings Call Summary

No call transcript available at time of writing 


Other indicators

Innovation score - Underperforming sector

Based on R&D activities. 


Deeper reading



END OF REPORT

x